256 related articles for article (PubMed ID: 3137252)
1. The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.
Shigemasa C; Abe K; Taniguchi S; Mitani Y; Ueta Y; Adachi T; Urabe K; Tanaka T; Yoshida A; Hori T
J Endocrinol Invest; 1988 Apr; 11(4):231-7. PubMed ID: 3137252
[TBL] [Abstract][Full Text] [Related]
2. The pituitary-thyroid axis in acromegaly.
Eskildsen PC; Kruse A; Kirkegaard C
Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
[TBL] [Abstract][Full Text] [Related]
3. Impaired pituitary thyrotroph function in uncontrolled type II diabetes mellitus: normalization on recovery.
Kabadi UM
J Clin Endocrinol Metab; 1984 Sep; 59(3):521-5. PubMed ID: 6430948
[TBL] [Abstract][Full Text] [Related]
4. Normalization of thyroid stimulating hormone levels in acromegalic patients after selective adenomectomy.
Tsuchiya H; Onishi T; Mori S; Lee S; Kohno H; Imanaka S; Saitoh Y; Mogami H; Uozumi T; Kumahara Y
Endocrinol Jpn; 1984 Dec; 31(6):687-95. PubMed ID: 6442697
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic-pituitary-thyroid axis in acromegaly.
Carmina E; Rosato F; Pirronello S; Jannì A
J Endocrinol Invest; 1983 Aug; 6(4):263-6. PubMed ID: 6417217
[TBL] [Abstract][Full Text] [Related]
6. Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotrophin.
Yoshinari M; Tokuyama T; Kuroda T; Sato K; Okazawa K; Mizokami T; Okamura K; Fujishima M
Clin Endocrinol (Oxf); 1992 Apr; 36(4):355-60. PubMed ID: 1424168
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
8. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
Marek J; Límanová Z; Srámková J
Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
[TBL] [Abstract][Full Text] [Related]
9. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
[TBL] [Abstract][Full Text] [Related]
10. The pituitary-thyroid axis in patients with pituitary disorders.
Eskildsen PC; Kruse A; Kirkegaard C
Horm Metab Res; 1989 Jul; 21(7):387-90. PubMed ID: 2506120
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
Díez JJ; Iglesias P; Sastre J; Gómez-Pan A
Eur J Endocrinol; 2000 Aug; 143(2):203-11. PubMed ID: 10913939
[TBL] [Abstract][Full Text] [Related]
12. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
13. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin and prolactin secretory patterns during 24-hours infusion of thyrotropin-releasing hormone in calves.
Ohlson DL; Davis SL; Anfinson MS; Klindt J
Neuroendocrinology; 1978; 26(3):163-73. PubMed ID: 98724
[TBL] [Abstract][Full Text] [Related]
15. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
16. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
Seo H; Refetoff S; Fang VS
Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
[TBL] [Abstract][Full Text] [Related]
17. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
Rösler A; Litvin Y; Hage C; Gross J; Cerasi E
J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
[TBL] [Abstract][Full Text] [Related]
18. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
Kaplan MM; Taft JA; Reichlin S; Munsat TL
J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
[TBL] [Abstract][Full Text] [Related]
19. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
Chang CC; Chen FW; Hsieh HC
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
[TBL] [Abstract][Full Text] [Related]
20. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
